Page last updated: 2024-08-23

substance p and Coronary Thrombosis

substance p has been researched along with Coronary Thrombosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chia, S; Fox, KA; Ludlam, CA; Megson, IL; Newby, DE1
Boon, NA; Flint, L; Fox, KA; Ludlam, CA; McLeod, AL; Newby, DE; Uren, NG; Webb, DJ1

Trials

1 trial(s) available for substance p and Coronary Thrombosis

ArticleYear
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
    Circulation, 2001, Apr-17, Volume: 103, Issue:15

    Topics: Area Under Curve; Blood Flow Velocity; Cardiac Catheterization; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Coronary Vessels; Endosonography; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; Plasminogen Activator Inhibitor 1; Regression Analysis; Risk Factors; Smoking; Substance P; Tissue Plasminogen Activator; Vasodilator Agents

2001

Other Studies

1 other study(ies) available for substance p and Coronary Thrombosis

ArticleYear
Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.
    Thrombosis research, 2003, Volume: 111, Issue:6

    Topics: Acetylcholine; Aged; Case-Control Studies; Coronary Restenosis; Coronary Thrombosis; Endothelium, Vascular; Female; Fibrinolysis; Humans; Male; Middle Aged; Nitroprusside; Platelet Aggregation; Regional Blood Flow; Stents; Substance P

2003